DrugBank

OCTOBER 4, 2024

Deal Structuring Deal structuring in pharmaceutical M&A requires a balance of financial, legal, and strategic considerations. These structures are particularly relevant in dealing with uncertainty about the future commercial potential of the target's products.

Pharmaceuticals 98

Pharmaceuticals Pharmaceutical Companies Therapies Marketing 98

Drug Patent Watch

DECEMBER 30, 2024

This article aims to provide a comprehensive overview of the key aspects of the regulatory framework, highlighting the requirements and challenges faced by pharmaceutical companies seeking to introduce generic drugs into the Japanese market. Retrieved from [link] Japan Pharmaceutical Manufacturers Association. Freyr Solutions.

Drug Development 52

Drug Development Clinical Pharmacology Clinical Trials Pharmaceutical Companies 52

Drug Patent Watch

OCTOBER 18, 2023

This chart shows the companies which have received the most New Product exclusivities in the past five years. New Product Development is one of the categories for which the FDA… The post Pharmaceutical companies with the most ‘New Product Exclusivity’ drugs appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 45

Pharmaceutical Companies Production Pharmaceuticals Drugs 45

Drug Patent Watch

OCTOBER 10, 2024

China has emerged as a significant player in the global generic drug active pharmaceutical ingredient (API) market. The country’s vast production capacity, low costs, and strategic location have made it an attractive destination for pharmaceutical companies seeking to source APIs.

Marketing 115

Marketing Pharmaceutical Companies Drugs Pharmaceuticals 115

thought leadership

FEBRUARY 10, 2025

For pharmaceutical companies, this shift presents both challenges and opportunities. In today's digital age, social media has transformed how businesses communicate with their audiences. Social media can significantly enhance brand visibility and patient engagement and have an impact on the overall healthcare sector.

Pharmaceutical Companies 66

Pharmaceutical Companies Pharmaceuticals Production 66

Fierce BioTech

MAY 14, 2024

Your Guide to the Ultimate Pharmaceutical Product Improvement Tool This white paper will review how automating the annual product quality review (APQR) process can help pharmaceutical companies simplify and optimize their product quality review process, to make informed product quality decisions quicker and on a more routine and proactive basis.

Production 52

Production Pharmaceuticals Pharmaceutical Companies 52

Drug Patent Watch

AUGUST 8, 2024

This chart shows the companies which have received the most New Product exclusivities in the past five years. New Product Development is one of the categories for which the FDA grants three years of…

Production 52

Production Pharmaceutical Companies Pharmaceuticals FDA 52

Drug Patent Watch

JUNE 27, 2024

Introduction Patent portfolios are critical assets for pharmaceutical companies, providing market exclusivity and protecting revenue streams for drug products. Effective management of drug patent portfolios requires strategic planning, ongoing evaluation, and adaptation to the evolving pharmaceutical landscape.

Pharmaceutical Companies 105

Pharmaceutical Companies Drugs Pharmaceuticals Production 105

Drug Discovery Today

JUNE 11, 2020

Webinar information:Join the experts on this free exclusive webinar on the 16th July 2020 at 2pm BST, hosted by West Pharmaceutical Services, Inc.

Pharmaceutical Companies 113

Pharmaceutical Companies Pharmaceuticals Production Marketing 113

Drug Patent Watch

AUGUST 9, 2023

This chart shows the companies which have received the most New Product exclusivities in the past five years. New Product Development is one of the categories for which the FDA… The post Pharmaceutical companies with the most ‘New Product Exclusivity’ drugs appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 40

Pharmaceutical Companies Production Pharmaceuticals Drugs 40

Drug Patent Watch

OCTOBER 18, 2022

This chart shows the companies which have received the most New Product exclusivities in the past five years. New Product Development is one of the categories for which the FDA…. The post Pharmaceutical companies with the most ‘New Product Exclusivity’ drugs appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 40

Pharmaceutical Companies Production Pharmaceuticals Drugs 40

Drug Patent Watch

OCTOBER 18, 2021

This chart shows the companies which have received the most New Product exclusivities in the past five years. New Product Development is one of the categories for which the FDA…. The post Pharmaceutical companies with the most ‘New Product Exclusivity’ drugs appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 40

Pharmaceutical Companies Production Pharmaceuticals Drugs 40

Drug Patent Watch

AUGUST 9, 2021

This chart shows the companies which have received the most New Product exclusivities in the past five years. New Product Development is one of the categories for which the FDA…. The post Pharmaceutical companies with the most ‘New Product Exclusivity’ drugs appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 40

Pharmaceutical Companies Production Pharmaceuticals Drugs 40

Drug Patent Watch

JUNE 18, 2024

These products contain the same active ingredients as their brand-name counterparts but are typically sold at a lower price point. Branded generics can be an attractive option for both consumers and pharmaceutical companies, offering cost savings while leveraging brand recognition. […] Source

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceuticals Production Marketing 105

Drug Channels

OCTOBER 1, 2022

Today’s guest post comes from Kylie Hall, Director of Product Management at ConnectiveRx. Kylie explains how new ways of harnessing patient data can transform the way pharmaceutical companies interact with patients and providers—and ultimately help improve adherence. Read on for Kylie’s insights.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceuticals Production Drugs 98

Drug Channels

OCTOBER 1, 2022

Today’s guest post comes from Kylie Hall, Director of Product Management at ConnectiveRx. Kylie explains how new ways of harnessing patient data can transform the way pharmaceutical companies interact with patients and providers—and ultimately help improve adherence. Read on for Kylie’s insights.

Pharmaceutical Companies 96

Pharmaceutical Companies Pharmaceuticals Production Drugs 96

FDA Law Blog: Biosimilars

MARCH 18, 2025

Koblitz Integral to the careful balance Congress struck when passing the Hatch-Waxman Amendments, the patent term extension (PTE) is intended to restore patent life that was consumed during regulatory review of an FDA-regulated product. The Court thus explained that interpreting the patent in 35 U.S.C.

Pharmaceutical Companies 59

Pharmaceutical Companies FDA Production Regulations 59

DrugBank

MARCH 7, 2024

Pharmaceutical researchers, in particular, have a keen interest in understanding the unfolding dynamics of this market. Inspired by its success, pharmaceutical companies are pursuing the development of drugs with similar therapeutic profiles, aiming to expand treatment options.

Pharmaceutical Companies 98

Pharmaceutical Companies Clinical Trials Pharmaceuticals Therapies 98

Pharmaceutical Development Group

AUGUST 9, 2021

Formulation chemistry is the systematic and step-by-step approach to pharmaceutical development. Nowadays, as the usage of medicines is increasing, pharmaceutical companies are more eager to bring manufacturing a new look in quality and performance. There are different tests to assess the quality of a pharmaceutical product.

Pharmaceuticals 52

Pharmaceuticals Pharmaceutical Companies FDA Approval Production 52

DS in Pharmatics

FEBRUARY 12, 2025

Cost estimation in drug product manufacturing is far from straightforward. Striking the right balance between operational efficiency and budget constraints poses a significant challenge for pharmaceutical companies. This balancing act becomes even more []

Production 52

Production Pharmaceutical Companies Compliance Drugs 52

Drug Patent Watch

DECEMBER 12, 2024

The pharmaceutical industry relies heavily on Contract Development and Manufacturing Organizations (CDMOs) to outsource various stages of drug development and manufacturing. Evaluating CDMO performance is a critical step in this process, ensuring that the chosen partner can meet the required standards and deliver high-quality products.

Drug Development 98

Drug Development Production Clinical Trials Pharmaceutical Companies 98

DS in Pharmatics

SEPTEMBER 25, 2023

A robust Quality Management System (QMS) is an important aspect of a Pharmaceutical company as it demonstrates a company’s Senior Management commitment to Quality. QMS instills the mindset that assures that the company will have qualified and trained individuals who focus on “Quality” throughout the lifecycle of the product.

Clinical Trials 52

Clinical Trials Production Pharmaceutical Companies Trials 52

Drug Target Review

AUGUST 6, 2024

Intense competition in oncology may lead companies to seek opportunities in less crowded fields, assessing the number of competitors and the status of competing therapies. Therapeutic areas with fewer competitors or novel targets can be attractive, offering companies the chance to establish leadership and differentiate their products.

Therapies 119

Therapies Pharmaceutical Companies Disease Treatment 119

DrugBank

JANUARY 22, 2025

Environmental Impacts of Traditional Pharmaceutical Production Traditional pharmaceutical manufacturing is complex, with each phase contributing to environmental degradation. The extraction and synthesis of active pharmaceutical ingredients (API) utilize vast amounts of water and energy.

Pharmaceuticals 52

Pharmaceuticals Pharmaceutical Companies Production Government 52

Drug Target Review

JANUARY 8, 2024

With cellular rejuvenation, our goal is to improve healthspan so as to maximise the number of healthy and productive years one has in their lifetime, not just their total number of years. a commercial stage pharmaceutical company. acquired by Teva Pharmaceuticals in 2014.

Science 145

Science Disease FDA Approval Clinical Trials 145

thought leadership

MAY 8, 2024

How ProPharma Can Help You Ensure Compliance with the New HTAR Requirements The new Health Technology Assessment Regulation (HTAR) will set new requirements for pharmaceutical companies seeking registration and market access in the European Union (EU) for their products.

Pharmaceutical Companies 59

Pharmaceutical Companies Compliance Pharmaceuticals Regulations 59

The Pharma Data

JANUARY 4, 2021

Drug discovery and development for these drug products is often carried out by academic investigators rather than by biopharmaceutical or pharmaceutical companies, said Patrizia Cavazzoni, acting director of the Center for Drug Evaluation and Research, in announcing the draft’s release. Suz Redfearn. Source link.

Production 52

Production FDA Pharmaceutical Companies Drugs 52

ACTO

MAY 25, 2023

Listen on Join us in this engaging episode to explore the critical elements of successful product launch training execution. Discover the key factors to consider when planning and executing product launch training, along with valuable insights on measuring sales performance. Tune in now!

Production 52

Production Pharmaceutical Companies Science Pharmaceuticals 52

ACTO

MAY 25, 2023

Listen on Join us in this engaging episode to explore the critical elements of successful product launch training execution. Discover the key factors to consider when planning and executing product launch training, along with valuable insights on measuring sales performance. Tune in now!

Production 52

Production Pharmaceutical Companies Science Pharmaceuticals 52

thought leadership

MARCH 12, 2025

When a pharmaceutical company completes clinical trials and prepares to launch a medical product, the focus often shifts to regulatory approvals, market access, and commercialization.

Compliance 40

Compliance Pharmaceuticals Pharmaceutical Companies Clinical Trials 40

PPD

MARCH 26, 2024

The PPD clinical research business of Thermo Fisher Scientific conducts an annual survey of more than 150 leaders at pharmaceutical companies around the globe to assess trends in drug discovery and development, including preferences around outsourcing and functional service provider (FSP) utilization.

Clinical Research 98

Clinical Research Pharmaceutical Companies Clinical Development Drug Development 98

The Pharma Data

OCTOBER 6, 2021

Adds 185,000 litres of biopharmaceutical production capacity High degree of digitalization and automation through smart technologies and artificial intelligence applications Multi-product setup enables production of a large variety of molecule formats Investment of more than 700 million EUR, creating 500 new jobs.

Production 52

Production Pharmaceutical Companies Treatment Disease 52

The Pharma Data

NOVEMBER 10, 2020

Herbert is a highly experienced senior executive with a proven track record in the pharmaceutical industry. The company is using this technology to transform therapies that are administered intravenously, and to enhance injectable products by reducing the volume and frequency of dosing.

Pharmaceuticals 52

Pharmaceuticals Engineering Pharmaceutical Companies Production 52

The Pharma Data

APRIL 1, 2021

Takeda Pharmaceutical Company Limited ( TSE:4502/NYSE:TAK ) (“Takeda”) today announced that it has completed the asset transfer associated with a portfolio of select non-core products in Japan to Teijin Pharma Limited (“Teijin Pharma”) for JPY 133.0 billion 1.? This asset transfer agreement was announced in February 2021.

Production 52

Production Pharmaceutical Companies Therapies Marketing 52

The Pharma Data

JANUARY 3, 2021

03, 2021 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced that Ocumension Therapeutics, a China-based ophthalmic pharmaceutical company traded on the Stock Exchange of Hong Kong (1477.HK),

Pharmaceuticals 52

Pharmaceuticals Pharmaceutical Companies Licensing Licensing 52

The Connected Lab

OCTOBER 6, 2021

Multiparameter sensor technologies are transforming workflow oversight, with tangible benefits for productivity and quality. Tools, such as machine learning and other kinds of artificial intelligence, are already being applied across pharmaceutical workflows to identify trends and anticipate issues before they turn into bigger problems.

Pharmaceuticals 52

Pharmaceuticals Laboratories Laboratory Informatics Pharmaceutical Companies 52

Eye on FDA

NOVEMBER 9, 2023

In it, language was used to assign a specific percentage in relation to the product’s efficacy. FDA said that the use of this specific statistic was misleading in that it did not use a validated methodology and did not agree with the means used to describe efficacy in the PI for the product.

FDA 88

FDA Pharmaceutical Companies Production Pharmaceuticals 88